Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Purpose: Low free testosterone (T) level in men is independently associated with presence and severity of Non-Alcoholic Steatohepatitis (NASH). The histological and molecular effects of oral testosterone prodrug LPCN 1144 treatment on hepatic fibrosis and NASH features are unknown. A metabolic syndrome-induced NASH model in rabbits consuming high fat diet (HFD) has been previously used to assess treatment effects of injectable T on hepatic fibrosis and NASH features. Here we present results on LPCN 1144 in this HFD-induced, NASH preclinical model. Methods: Male rabbits were randomly assigned to five groups: regular diet (RD), HFD, HFD + 1144 vehicle (HFD + Veh), HFD + 1144 (1144), and HFD + 1144 + α-tocopherol (1144 + ALPHA). Rabbits were sacrificed after 12 weeks for liver histological, biochemical and genetic analyses. Histological scores were obtained through Giemsa (inflammation), Masson’s trichrome (steatosis and ballooning), and Picrosirius Red (fibrosis) staining. Results: Compared to RD, HFD and HFD + Veh significantly worsened NASH features and hepatic fibrosis. Considering HFD and HFD + Veh arms, histological and biomarker features were not significantly different. Both 1144 and 1144 + ALPHA arms improved mean histological scores of NASH as compared to HFD arm. Importantly, percentage of fibrosis was improved in both 1144 ( p < 0.05) and 1144 + ALPHA ( p = 0.05) treatment arms vs. HFD. Both treatment arms also reduced HFD-induced inflammation and fibrosis mRNA markers. Furthermore, 1144 treatments significantly improved HFD-induced metabolic dysfunctions. Conclusions: Histological and biomarker analyses demonstrate that LPCN 1144 improved HFD-induced hepatic fibrosis and NASH biochemical, biomolecular and histochemical features. These preclinical findings support a therapeutic potential of LPCN 1144 in the treatment of NASH and of hepatic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Targeting androgen receptors (ARs) with bioidentical testosterone such as the agonist LPCN 1144, offered treatment potential in NASH as shown in a rabbit NASH model in which the percentage of fibrosis was improved upon AR activation.[199]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
A Simple Practice Guide for Dose Conversion between Animals and Human
Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
American Association for the Study of Liver Diseases
Popper, H. (1960) · Gastroenterology · doi:10.1016/s0016-5085(60)80094-7 · Cited by 903
Stefan, N., Häring, H.-U., & Cusi, K. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30154-2 · Cited by 837
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L. M., Lundbom, N., Rissanen, A., Ridderstråle, M., Groop, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.005 · Cited by 804
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
Montagner, A., Polizzi, A., Fouché, E., Ducheix, S., Lippi, Y., Lasserre, F., Barquissau, V., Régnier, M., Lukowicz, C., Benhamed, F., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310798 · Cited by 736
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice
Wang, Y., Nakajima, T., Gonzalez, F. J., & Tanaka, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062061 · Cited by 540
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Kitade, H., Chen, G., Ni, Y., & Ota, T. (2017) · Nutrients · doi:10.3390/nu9040387 · Cited by 492
Preclinical models of non-alcoholic fatty liver disease
Santhekadur, P. K., Kumar, D. P., & Sanyal, A. J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.031 · Cited by 380
Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions.
Snel, M., Jonker, J. T., Schoones, J., Lamb, H., de Roos, A., Pijl, H., Smit, J. W. A., Meinders, A. E., & Jazet, I. M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/983814 · Cited by 368
ZUMOFF, B., STRAIN, G. W., MILLER, L. K., ROSNER, W., SENIE, R., SERES, D. S., & ROSENFELD, R. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-929 · Cited by 349
CARPINO, G., MORINI, S., GINANNICORRADINI, S., FRANCHITTO, A., MERLI, M., SICILIANO, M., GENTILI, F., ONETTIMUDA, A., BERLOCO, P., & ROSSI, M. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.11.009 · Cited by 309
Targher, G., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3093 · Cited by 297
Inflammation and impaired adipogenesis in hypertrophic obesity in man
Gustafson, B., Gogg, S., Hedjazifar, S., Jenndahl, L., Hammarstedt, A., & Smith, U. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00377.2009 · Cited by 291
Bril, F., Barb, D., Portillo‐Sanchez, P., Biernacki, D., Lomonaco, R., Suman, A., Weber, M. H., Budd, J. T., Lupi, M. E., & Cusi, K. (2017) · Hepatology · doi:10.1002/hep.28985 · Cited by 288
PPARs and nonalcoholic fatty liver disease
Liss, K. H. H., & Finck, B. N. (2017) · Biochimie · doi:10.1016/j.biochi.2016.11.009 · Cited by 275
From NAFLD to MAFLD: when pathophysiology succeeds
Tilg, H., & Effenberger, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0316-6 · Cited by 257
Goto, T., Lee, J.-Y., Teraminami, A., Kim, Y.-I., Hirai, S., Uemura, T., Inoue, H., Takahashi, N., & Kawada, T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011320 · Cited by 217
Obesity, body fat distribution and sex hormones in men.
Haffner, S. M., Valdez, R. A., D, M. P. S. M., & Katz, M. S. (1993) · PubMed · Cited by 213
Vignozzi, L., Morelli, A., Sarchielli, E., Comeglio, P., Filippi, S., Cellai, I., Maneschi, E., Serni, S., Gacci, M., Carini, M., et al. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0289 · Cited by 185
Self-citationTraish, A. M., Bolaños, J., Nair, S., Saad, F., & Morgentaler, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120549 · Cited by 172
Filippi, S., Vignozzi, L., Morelli, A., Chavalmane, A. K., Sarchielli, E., Fibbi, B., Saad, F., Sandner, P., Ruggiano, P., Vannelli, G. B., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01467.x · Cited by 166
Self-citationSishi, B., Loos, B., Ellis, B., Smith, W., du Toit, E. F., & Engelbrecht, A.-M. (2011) · Experimental Physiology · doi:10.1113/expphysiol.2010.054189 · Cited by 162
Alkhouri, N., Tamimi, T., Yerian, L. M., López, R., Zein, N. N., & Feldstein, A. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1075-y · Cited by 125
Insulin-sensitive obesity in humans – a ‘favorable fat’ phenotype?
Samocha‐Bonet, D., Chisholm, D. J., Tonks, K. T. T., Campbell, L. V., & Greenfield, J. R. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.005 · Cited by 123
Mu, W., Cheng, X.-F., Liu, Y., Lv, Q.-Z., Liu, G.-L., Zhang, J.-G., & Li, X.-Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01566 · Cited by 123
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
Rhee, E. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.3.226 · Cited by 119
Morelli, A., Sarchielli, E., Comeglio, P., Filippi, S., Vignozzi, L., Marini, M., Rastrelli, G., Maneschi, E., Cellai, I., Persani, L., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.017 · Cited by 107
Self-citationCorona, G., Mannucci, E., Petrone, L., Schulman, C., Balercia, G., Fisher, A. D., Chiarini, V., Forti, G., & Maggi, M. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00498.x · Cited by 98
Self-citationTestosterone treatment improves metabolic syndrome-induced adipose tissue derangements
Maneschi, E., Morelli, A., Filippi, S., Cellai, I., Comeglio, P., Mazzanti, B., Mello, T., Calcagno, A., Sarchielli, E., Vignozzi, L., et al. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0333 · Cited by 90
Self-citationInflammation in nonalcoholic steatohepatitis
Harmon, R. C., Tiniakos, D. G., & Argo, C. K. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.21 · Cited by 84
Vignozzi, L., Filippi, S., Comeglio, P., Cellai, I., Sarchielli, E., Morelli, A., Rastrelli, G., Maneschi, E., Galli, A., Vannelli, G. B., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.014 · Cited by 84
Self-citationMorelli, A., Comeglio, P., Filippi, S., Sarchielli, E., Cellai, I., Vignozzi, L., Yehiely-Cohen, R., Maneschi, E., Gacci, M., Carini, M., et al. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.02.007 · Cited by 84
Self-citationINT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function
Comeglio, P., Cellai, I., Mello, T., Filippi, S., Maneschi, E., Corcetto, F., Corno, C., Sarchielli, E., Morelli, A., Rapizzi, E., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0557 · Cited by 73
Self-citationPhenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity
Chen, D. L., Liess, C., Poljak, A., Xu, A., Zhang, J., Thoma, C., Trenell, M., Milner, B., Jenkins, A. B., Chisholm, D. J., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2712 · Cited by 70
Bhatt, B. A., Dube, J. J., Dedousis, N., Reider, J. A., & O’Doherty, R. M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00097.2005 · Cited by 69
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
Maneschi, E., Vignozzi, L., Morelli, A., Mello, T., Filippi, S., Cellai, I., Comeglio, P., Sarchielli, E., Calcagno, A., Mazzanti, B., et al. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0109 · Cited by 68
Self-citationComeglio, P., Filippi, S., Sarchielli, E., Morelli, A., Cellai, I., Corcetto, F., Corno, C., Maneschi, E., Pini, A., Adorini, L., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.01.010 · Cited by 66
Self-citationHepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
Overi, D., Carpino, G., Franchitto, A., Onori, P., & Gaudio, E. (2020) · Cells · doi:10.3390/cells9030590 · Cited by 66
Diet-Induced Rabbit Models for the Study of Metabolic Syndrome
Lozano, W. M., Arias-Mutis, O. J., Calvo, C. J., Chorro, F. J., & Zarzoso, M. (2019) · Animals · doi:10.3390/ani9070463 · Cited by 53
Arias-Mutis, O. J., Marrachelli, V. G., Ruiz‐Saurí, A., Alberola, A. M., Morales, J. M., Such‐Miquel, L., Monleón, D., Chorro, F. J., Such, L., & Zarzoso, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178315 · Cited by 42
Gabbia, D., Roverso, M., Guido, M., Sacchi, D., Scaffidi, M., Carrara, M., Orso, G., Russo, F. P., Floreani, A., Bogialli, S., et al. (2019) · Nutrients · doi:10.3390/nu11071602 · Cited by 42
Maneschi, E., Cellai, I., Aversa, A., Mello, T., Filippi, S., Comeglio, P., Bani, D., Guasti, D., Sarchielli, E., Salvatore, G., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.01.015 · Cited by 32
Self-citationTestosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model
Sarchielli, E., Comeglio, P., Filippi, S., Cellai, I., Guarnieri, G., Guasti, D., Rapizzi, E., Rastrelli, G., Bani, D., Vannelli, G. B., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0532 · Cited by 27
Self-citationLPCN 1144 Resolves NAFLD in Hypogonadal Males
Albhaisi, S. A. M., Kim, K., Baker, J., Chidambaram, N., Patel, M. V., Charlton, M., & Sanyal, A. J. (2020) · Hepatology Communications · doi:10.1002/hep4.1571 · Cited by 22
Self-citationMiyauchi, S., Miyake, T., Miyazaki, M., Eguchi, T., Niiya, T., Yamamoto, S., Senba, H., Furukawa, S., Matsuura, B., & Hiasa, Y. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.13000 · Cited by 19
Evaluation of fatty liver fibrosis in rabbits using real-time shear wave elastography
Lu, Y., Jia, W. P., Tang, Y., Yuan, Y., Huang, Y., Zhang, Y., & Li, Y. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1749 · Cited by 16
Cited by
Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis
Corona, G., Vena, W., Pizzocaro, A., Pallotti, F., Paoli, D., Rastrelli, G., Baldi, E., Cilloni, N., Gacci, M., Semeraro, F. F., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01801-x · Cited by 77
Self-citationNuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45
Comeglio, P., Guarnieri, G., Filippi, S., Cellai, I., Acciai, G., Holyer, I., Zetterberg, F. R., Leffler, H., Kahl-Knutson, B., Sarchielli, E., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1430109 · Cited by 19
Self-citationAssociation of sex hormones with hepatic steatosis in men with chronic hepatitis B
Chen, Q., Zhao, L., Mei, L., Zhong, R., Han, P., Yang, H., Li, Q., & Li, J. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.05.022 · Cited by 15
Metabolic reprogramming drives pancreatic β cell neogenesis from α cells
Zhang, Y., Lu, G., Xie, W., Xu, P. H., Liu, C., Babošová, O., Reilly, J. C., Li, Z., Chen, L., Zhou, L., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02293-z · Cited by 4
Metadata
- Authors
- Comeglio, P., Sarchielli, E., Filippi, S., Cellai, I., Guarnieri, G., Morelli, A., Rastrelli, G., Maseroli, E., Cipriani, S., Mello, T., Galli, A., Bruno, B. J., Kim, K., Vangara, K., Papangkorn, K., Chidambaram, N., Patel, M. V., Maggi, M., & Vignozzi, L.
- Affiliations
- University of Florence (IT)
- Lipocine (United States) (US)
- Istituto Nazionale Biostrutture e Biosistemi (IT)
- Corresponding author
- Vignozzi, L.
- ORCID
- Venue
- Journal of Endocrinological Investigation
- Published
- 2021-02-13
- Volume
- 44
- Issue
- 10
- Pages
- 2175-2193
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- PMC
- PMC8421272
- OpenAlex
- W3130590219
- Cited by
- 7
- References
- 62
- Citations by year
- 2026: 2 · 2024: 1 · 2022: 2 · 2021: 2
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Endocrinological Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion, other-oa)
- Funders
- Lipocine Inc.
- Università degli Studi di Firenze
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- nonalcoholic steatohepatitis, liver fibrosis, high-fat diet, liver health, metabolic regulation, alpha-tocopherol, liver inflammation, steatosis, metabolic syndrome, rabbit model
- MeSH terms
- Androgens, Animals, Disease Models, Animal, Fibrosis, Inflammation, Male, Prodrugs, Rabbits, Testosterone, Metabolic Syndrome, Diet, High-Fat, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.